These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

890 related articles for article (PubMed ID: 18575188)

  • 1. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
    Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
    Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.
    Bennett DE; Bertagnolio S; Sutherland D; Gilks CF
    Antivir Ther; 2008; 13 Suppl 2():1-13. PubMed ID: 18578063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. World Health Organization/HIVResNet Drug Resistance Laboratory Strategy.
    Bertagnolio S; Derdelinckx I; Parker M; Fitzgibbon J; Fleury H; Peeters M; Schuurman R; Pillay D; Morris L; Tanuri A; Gershy-Damet GM; Nkengasong J; Gilks CF; Sutherland D; Sandstrom P
    Antivir Ther; 2008; 13 Suppl 2():49-57. PubMed ID: 18575191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV drug resistance transmission threshold survey in Bangkok, Thailand.
    Sirivichayakul S; Phanuphak P; Pankam T; O-Charoen R; Sutherland D; Ruxrungtham K
    Antivir Ther; 2008; 13 Suppl 2():109-13. PubMed ID: 18575199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of transmitted HIV drug resistance in the Manzini-Mbabane corridor, Swaziland, in 2006.
    Maphalala G; Okello V; Mndzebele S; Gwebu P; Mulima N; Dlamini S; Nhlabatsi B; Ginindza T; Ghebrenegus Y; Ntilivamunda A; Mwanyumba F; Ledwaba J; Pillay V; Bennett DE
    Antivir Ther; 2008; 13 Suppl 2():95-100. PubMed ID: 18575197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance of transmitted HIV drug resistance among women attending antenatal clinics in Dar es Salaam, Tanzania.
    Somi GR; Kibuka T; Diallo K; Tuhuma T; Bennett DE; Yang C; Kagoma C; Lyamuya EF; Swai RO; Kassim S
    Antivir Ther; 2008; 13 Suppl 2():77-82. PubMed ID: 18575194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of transmitted HIV drug resistance with the World Health Organization threshold survey method in Lilongwe, Malawi.
    Kamoto K; Aberle-Grasse J;
    Antivir Ther; 2008; 13 Suppl 2():83-7. PubMed ID: 18575195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV drug resistance threshold survey using specimens from voluntary counselling and testing sites in Hanoi, Vietnam.
    Nguyen HT; Duc NB; Shrivastava R; Tran TH; Nguyen TA; Thang PH; McNicholl JM; Leelawiwat W; Chonwattana W; Sidibe K; Fujita M; Luu CM; Kakkar R; Bennett DE; Kaplan J; Cosimi L; Wolfe MI
    Antivir Ther; 2008; 13 Suppl 2():115-21. PubMed ID: 18575200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Threshold survey evaluating transmitted HIV drug resistance among public antenatal clinic clients in Addis Ababa, Ethiopia.
    Abegaz WE; Grossman Z; Wolday D; Ram D; Kaplan J; Sibide K; Wuhib T; Ismael S; Nkengasong J; Mekonen T; Berhanu H; Messele T; Lulseged S; Maayan S; Mengistu Y
    Antivir Ther; 2008; 13 Suppl 2():89-94. PubMed ID: 18575196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early warning indicators for HIV drug resistance in Malawi.
    Hedt BL; Wadonda-Kabondo N; Makombe S; Harries AD; Schouten EJ; Limbambala E; Hochgesang M; Aberle-Grosse J; Kamoto K
    Antivir Ther; 2008; 13 Suppl 2():69-75. PubMed ID: 18575193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment.
    Bennett DE; Myatt M; Bertagnolio S; Sutherland D; Gilks CF
    Antivir Ther; 2008; 13 Suppl 2():25-36. PubMed ID: 18575189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early warning indicators for population-based monitoring of HIV drug resistance in 6 African countries.
    Sigaloff KC; Hamers RL; Menke J; Labib M; Siwale M; Ive P; Botes ME; Kityo C; Mandaliya K; Wellington M; Osibogun A; Geskus RB; Stevens WS; van Vugt M; Rinke de Wit TF;
    Clin Infect Dis; 2012 May; 54 Suppl 4():S294-9. PubMed ID: 22544190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004.
    Pillay V; Ledwaba J; Hunt G; Rakgotho M; Singh B; Makubalo L; Bennett DE; Puren A; Morris L
    Antivir Ther; 2008; 13 Suppl 2():101-7. PubMed ID: 18575198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of a national monitoring and evaluation system for rapid expansion of antiretroviral treatment in Malawi.
    Lowrance D; Filler S; Makombe S; Harries A; Aberle-Grasse J; Hochgesang M; Libamba E
    Trop Med Int Health; 2007 Mar; 12(3):377-81. PubMed ID: 17313509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National adult antiretroviral therapy guidelines in resource-limited countries: concordance with 2003 WHO guidelines?
    Beck EJ; Vitoria M; Mandalia S; Crowley S; Gilks CF; Souteyrand Y
    AIDS; 2006 Jul; 20(11):1497-502. PubMed ID: 16847404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing world.
    Bennett DE
    Curr Opin Infect Dis; 2006 Dec; 19(6):607-14. PubMed ID: 17075338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV resistance and the developing world.
    Gupta RK; Pillay D
    Int J Antimicrob Agents; 2007 May; 29(5):510-7. PubMed ID: 17346940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to antiretroviral drugs in newly diagnosed, young treatment-naïve HIV-positive pregnant women in the province of KwaZulu-Natal, South Africa.
    Parboosing R; Naidoo A; Gordon M; Taylor M; Vella V
    J Med Virol; 2011 Sep; 83(9):1508-13. PubMed ID: 21739439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dried blood spot specimens are a suitable alternative sample type for HIV-1 viral load measurement and drug resistance genotyping in patients receiving first-line antiretroviral therapy.
    Rottinghaus EK; Ugbena R; Diallo K; Bassey O; Azeez A; Devos J; Zhang G; Aberle-Grasse J; Nkengasong J; Yang C
    Clin Infect Dis; 2012 Apr; 54(8):1187-95. PubMed ID: 22412066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public-sector ART in the Free State Province, South Africa: community support as an important determinant of outcome.
    Wouters E; Van Damme W; Van Loon F; van Rensburg D; Meulemans H
    Soc Sci Med; 2009 Oct; 69(8):1177-85. PubMed ID: 19692165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.